Insurance, race, and socioeconomic disparities in systemic therapy receipt for melanoma in the United States: a systematic review.

ABSTRACT:

Background

Although evidence suggests disparities in melanoma treatment, no comprehensive summary exists on whether insurance type, race/ethnicity, or socioeconomic status consistently influence systemic therapy receipt. Understanding these associations may inform strategies to reduce inequities.

Methods

We conducted a systematic review of United States (US) based studies assessing systemic therapy receipt by insurance, socioeconomic status, and race/ethnicity. Searches of PubMed, Embase, and Web of Science were performed through July 10, 2025. Evidence quality was evaluated using the Oxford Center for Evidence-Based Medicine.

Results

Of 6,604 records screened and 223 full-texts reviewed, 30 retrospective cohort studies were included, encompassing 1,212,437 melanoma p

SUBMITTER: Zhang S 

PROVIDER: S-EPMC12928661 | biostudies-literature | 2026 Dec

REPOSITORIES: biostudies-literature